Business Context and Reporting Period
This Form 6-K filing by Alcon, Inc., a leading global eye care company, covers the month of December 2002. The report primarily discloses a significant legal development regarding patent litigation against Nidek, rather than providing routine financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a material legal event and does not contain financial statements or performance metrics for the period.
Material Changes and Legal Developments
A District Judge vacated a unanimous jury verdict that had previously found Nidek willfully infringed two of Alcon/Summit patents. The original verdict, reached on September 25, 2002, awarded damages to Alcon. The judge ruled there was insufficient evidence to support the jury's decision, entering judgment in Nidek's favor. This represents a material adverse change in the status of the litigation originally filed by Summit Technology, Inc. in December 1998.
Outlook, Risks, and Management Commentary
Management states that Alcon believes the original jury verdict was correct and fully supported by the evidence. Consequently, the company intends to appeal the judge's ruling. The filing includes a caution regarding forward-looking statements, noting that actual results may differ materially due to uncertainties, specifically the risk that the company may not be successful in its appeal.
Key Facts for Investor Verification
- Alcon is appealing a court ruling that vacated a favorable jury verdict against Nidek regarding patent infringement.
- The litigation concerns two crucial patents related to the Nidek excimer laser.
- No financial performance data is included in this specific filing.
- Management asserts the original verdict was supported by evidence, but the outcome of the appeal remains uncertain.